Cargando…
MAP17, a ROS-dependent oncogene
MAP17 is a small 17 kDa non-glycosylated membrane protein previously identified as being overexpressed in carcinomas. Breast tumor cells that overexpress MAP17 show an increased tumoral phenotype with enhanced proliferative capabilities both in the presence or the absence of contact inhibition, decr...
Autor principal: | Carnero, Amancio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434504/ https://www.ncbi.nlm.nih.gov/pubmed/22973555 http://dx.doi.org/10.3389/fonc.2012.00112 |
Ejemplares similares
-
The cargo protein MAP17 (PDZK1IP1) regulates the immune microenvironment
por: García-Heredia, José M., et al.
Publicado: (2017) -
Dr. Jekyll and Mr. Hyde: MAP17’s up-regulation, a crosspoint in cancer and inflammatory diseases
por: García-Heredia, José M., et al.
Publicado: (2018) -
The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models
por: Carnero, Amancio, et al.
Publicado: (2014) -
NAMPT as a Dedifferentiation-Inducer Gene: NAD(+) as Core Axis for Glioma Cancer Stem-Like Cells Maintenance
por: Lucena-Cacace, Antonio, et al.
Publicado: (2019) -
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness
por: Espinosa-Sánchez, Asunción, et al.
Publicado: (2020)